Back to Search Results

A phase II randomized study of the combination of Ribociclib plus goserelin acetate with Hormonal Therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with hormone receptor-positive/HER2-negative inoperable locally adva

premenopausal, perimenopausal, HR+, LABC, MBC

Condition:	Intervention:	Phase:
Breast Cancer		II

Status:	Open (Show results)
Volunteers Required:	Yes
Published Date:	20 October 2020

Term of Use/Disclaimer

All information provided within this web and mobile application is intended for general information and is provided on the understanding that no surgical and medical advice or recommendation is being rendered. Please do not disregard the professional advice of your physician.

Principal Investigator

Assoc Prof - Yoon Sim - Yap

Senior Consultant

Clinical Trials ＆ Epidemiological Sciences

National Cancer Centre Singapore

Contact Details

For enquiries, please email [email protected]

Published on 20 October 2020